Charts

25 Sep, 2022

News

23 Sep, 2022
Gainers Kiromic BioPharma, Inc. (NASDAQ: KRBP) shares jumped 87% to $0.4791. Kiromic BioPharma, said on Sept. 15, that the company ...
U.S. stocks traded lower, with the Dow Jones dropping around 400 points on Friday. Here are some big stocks recording gains in ...
14 Sep, 2022
Every investor in Regencell Bioscience Holdings Limited ( NASDAQ:RGC ) should be aware of the most powerful shareholder...
12 Sep, 2022
Regencell Bioscience Holdings Limited (Nasdaq: RGC) (“Regencell”) today announced its interim results from its second efficacy trial.
07 Sep, 2022
06 Sep, 2022
In trading on Tuesday, shares of Regencell Bioscience Holdings Ltd (RGC) crossed above their 200 day moving average of $30.65, changing hands as high as $34.00 per share. Regencell Bioscience Holdings Ltd shares are currently trading up about 12.4% on the day..
02 Aug, 2022
2021 was the busiest year for deals since 2000, with a record-breaking IPO rush of 1,035 listings in the US, with the biotech and ...
27 Jun, 2022
A handful of small companies are working on long Covid treatments — sorely needed tools as the number of those afflicted grows.
23 Jun, 2022
Gainers Ocean Bio-Chem, Inc. (NASDAQ: OBCI) shares climbed 117.2% to close at $12.86 on Wednesday after the company announced it ...
20 Jun, 2022
By Beth Senko, CFA NASDAQ:RGC Investors have faced challenging and volatile markets so far in 2022 as they sort through issues of inflation, supply chain disruption, continued covid issues, rising interest rates, and the disruption of the war in Ukraine. The S&P 500 has come close to bear market levels, down 19% in mid-June. Times of turbulence affect all stocks, large and small. It can be
06 Jun, 2022
Photo by Yan Krukov from Pexels This post contains sponsored advertising content. This content is for informational purposes only and ...
02 Jun, 2022
10:10
FinancialContent
Gainers Missfresh Limited (NASDAQ: MF) jumped 51.1% to close at $0.2450 on Wednesday. Spark Networks SE (NASDAQ: LOV) jumped ...
01 Jun, 2022
Gainers Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) shares jumped 63.9% to $3.9990 after the company announced the USPTO ...
24 May, 2022
By Beth Senko, CFA NASDAQ:RGC Founded in 2014, Hong Kong-based Regencell Bioscience (NASDAQ:RGC) is an early clinical stage bioscience company using Traditional Chinese Medicine (TCM) approach to develop standardized TCM formulas to holistically treat autism spectrum disorder (ASD) and attention deficit hyperactivity disorder (ADHD) in children, and infectious diseases such as the coronavirus
18 May, 2022
Is the United States heading toward a recession? This has been the looming question on the minds of Americans since inflation topped ...
Those following along with Regencell Bioscience Holdings Limited ( NASDAQ:RGC ) will no doubt be intrigued by the...
16 May, 2022
Regencell Bioscience Holdings Limited (NASDAQ: RGC) (“Regencell” or the “Company”), an early-stage bioscience company focusing on the research, development and commercialization of Traditional Chinese Medicine (“TCM”) for the treatment of neurocognitive disorders and degenerations, as well as infectious diseases affecting people’s immune system, announced that Yat-Gai Au, the Company’s Chairman and CEO, made purchases of ordinary shares in Regencell (“Ordinary Shares”) totaling $5.03 million.
09 May, 2022
When we enter a period of economic uncertainty, the phrase "recession-proof stocks" is tossed about, but really the only ...
14 Apr, 2022
By Beth Senko, CFA NASDAQ:RGC Asia is in the throes of the omicron variant, and Hong Kong is at the center. Although Hong Kong has been successful in limiting cases in past waves, the omicron variant is so contagious that current public health measures have been inadequate. According to the New York Times, the death rate in Hong Kong in early March exceeded 25 per 100,000 residents – higher than
07 Apr, 2022
The big shareholder groups in Regencell Bioscience Holdings Limited ( NASDAQ:RGC ) have power over the company. Large...
01 Mar, 2022
LOS ANGELES, CA / ACCESSWIRE / March 1, 2022 / SNN Network, The Official Small-, Micro- and Nano-Cap News Source™, today published a new Video Interview with the team from Regencell Bioscience Holdings Limited (NASDAQ:RGC), including: Jay Lee, CEO of Regencell Bioscience Asia Limited, and Paul Niewiadomski, Independent Director. Regencell is an early-stage bioscience company focuses on the research, development and commercialization of TCM for the treatment of neurocognitive disorders and degene
18 Feb, 2022
Gainers HOOKIPA Pharma (NASDAQ:HOOK) stock moved upwards by 8.5% to $2.69 during Friday's after-market session. HOOKIPA Pharma's ...
17 Feb, 2022
Regencell Bioscience Holdings Limited(NASDAQ: RGC) announced the results from the EARTH efficacy trial of its COVID-19 ...
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Amylyx's ALS Treatment ...
Regencell Bioscience Holdings Limited (NASDAQ: RGC) (“Regencell” or the “Company”) today announced the results from an analysis of a total of 37 individuals enrolled in its Evaluation and Assessment of RGC-COV19TM TCM through a Holistic approach (“EARTH”) efficacy trial conducted by Regencell Bioscience Asia Limited (“Regencell Asia”) of its novel COVID-19 oral TCM candidate RGC-COV19TM (Regencell Bioscience (RGCA-CV01) liquid formulation). The results have yet to be peer reviewed. Upon successful completion of the EARTH efficacy trial, RGC-COV19TM could be used more broadly for the treatment of the population who seek a natural and holistic approach to effectively reduce and eliminate COVID-19 symptoms and to reduce the risk of hospitalization and death.
HONG KONG, February 17, 2022--Regencell Bioscience Holdings Limited (NASDAQ: RGC) ("Regencell" or the "Company") today announced the results from an analysis of a total of 37 individuals enrolled in its Evaluation and Assessment of RGC-COV19TM TCM through a Holistic approach ("EARTH") efficacy trial conducted by Regencell Bioscience Asia Limited ("Regencell Asia") of its novel COVID-19 oral TCM candidate RGC-COV19TM (Regencell Bioscience (RGCA-CV01) liquid formulation). The results have yet to b
31 Jan, 2022
10:03
FinancialContent
Gainers Knightscope, Inc. (NASDAQ: KSCP) surged 175.6% to close at $3.40 on Friday. The company, on Thursday, priced its IPO at ...
29 Dec, 2021
09:06
FinancialContent
Gainers Insignia Systems, Inc. (NASDAQ: ISIG) shares climbed 64.8% to close at $19.02 on Tuesday as traders circulated a social ...
28 Dec, 2021
Healthcare IPOs, 2seventy bio, Inc., Regencell Bioscience Holdings Limited, and Biofrontera Inc. have generated significant returns since their stock market debut and could be ideal additions to one’s watchlist.
13 Dec, 2021
Regencell Bioscience Holdings Limited (NASDAQ: RGC) (“Regencell” or the “Company”), an early-stage bioscience company focuses on the research, development and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, as well as infectious diseases affecting people’s immune system, announced the appointment of Dr. William Wing-Yan Lo, JP to its Board of Directors, effective immediately, to strengthen its Board of Director and fill the vacancy resulting from the resignation of a former director in November of this year. Dr. Lo will act as the chairperson of the audit committee and the member of the compensation committee and the nomination and corporate governance committee.
22 Nov, 2021
Regencell Bioscience Holdings Limited (NASDAQ: RGC) (“Regencell” or the “Company”), an early-stage bioscience company focuses on the research, development and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, as well as infectious diseases affecting people’s immune system, announced that Yat-Gai Au, the Company’s Chairman & CEO, made Ordinary Share purchases of Regencell (“Ordinary Shares”) totaling $1,125,807.
Regencell Bioscience Holdings Limited (NASDAQ: RGC) (“Regencell” or the “Company”), an early-stage bioscience company focuses on the research, development and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, as well as infectious diseases affecting people’s immune system, announced that the ordinary shares of the Company will be added to the MSCI World Micro Cap Index on November 30, 2021 after the close of market (effective December 1, 2021).
02 Nov, 2021
08:55
FinancialContent
Gainers ABVC BioPharma, Inc. (NASDAQ: ABVC) shares climbed 137.4% to close at $6.03 on Monday on abnormally-high volume. The stock ...
By Beth Senko, CFA NASDAQ:RGC Founded in 2014, Hong Kong-based Regencell Bioscience (NASDAQ:RGC) is an early clinical stage bioscience company using a traditional Chinese medicine (TCM) approach to develop standardized TCM formulas to holistically treat different elements of autism spectrum disorder (ASD) and attention deficit hyperactivity disorder (ADHD) in adolescents, and infectious diseases
Regencell Bioscience Hld shows rising price performance, earning an upgrade to its IBD Relative Strength Rating.
01 Nov, 2021
Gainers ABVC BioPharma, Inc. (NASDAQ: ABVC) shares jumped 250% to $8.91 on abnormally-high volume. The stock is seeing increased ...
25 Oct, 2021
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100..
19 Oct, 2021
The big shareholder groups in Regencell Bioscience Holdings Limited ( NASDAQ:RGC ) have power over the company...
12 Oct, 2021
Gainers ESS Tech Inc (NYSE: GWH) shares jumped 96.4% to $20.46. ESS Inc, the Bill Gates-backed battery maker went public on the ...
09:01
FinancialContent
Gainers Protagonist Therapeutics, Inc. (NASDAQ: PTGX) shares jumped 93.9% to close at $35.36 on Monday. The FDA removed the full ...
30 Sep, 2021
Gainers FibroGen (NASDAQ:FGEN) stock moved upwards by 4.99% to $10.73 during Thursday's after-market session. The company's market ...
Gainers OptimizeRx (NASDAQ:OPRX) stock increased by 12.12% to $84.05 during Thursday's pre-market session. The ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning, trader! We're starting off your Thursday the right way with a look at the biggest pre-market stock movers for today! The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now Analyst Who Found Microsoft at $0.38 Names #1 Pick for the AI Boom America’s #1 EV Stock Still Flying Under the Radar
09:07
FinancialContent
Gainers Paltalk, Inc. (NASDAQ: PALT) shares jumped 60.1% to close at $8.39 on Wednesday. Smart Share Global Limited (NASDAQ: EM) ...
29 Sep, 2021
Gainers Regencell Bioscience (NASDAQ:RGC) shares rose 30.57% to $30.02 during Wednesday's after-market session. Today's trading ...
Gainers NuCana (NASDAQ:NCNA) stock increased by 22.36% to $2.9 during Wednesday's regular session. The current ...
Gainers Paltalk, Inc. (NASDAQ: PALT) shares climbed 37% to $7.18. NuCana plc (NASDAQ: NCNA) jumped 31.4% to $3.1150. The FDA ...
27 Sep, 2021
09:41
FinancialContent
Gainers ZIVO Bioscience, Inc. (NASDAQ: ZIVO) shares climbed 58% to close at $5.45 on Friday. Clearwater Analytics Holdings, ...
24 Sep, 2021
Gainers Molecular Templates (NASDAQ:MTEM) stock rose 14.13% to $7.59 during Friday's regular session. Trading volume ...
23 Sep, 2021
Gainers Amplitude Healthcare Acquisition Corporation (NASDAQ: AMHC) rose 61.8% to $16.55 in pre-market trading. The company ...
09:14
FinancialContent
Gainers Marin Software Incorporated (NASDAQ: MRIN) shares jumped 61.9% to close at $9.21 on Wednesday following an announcement ...
02 Sep, 2021
Regencell Bioscience Holdings Ltd's(NASDAQ: RGC) subsidiary in Hong Kong hasentered into a joint venture ...
Regencell Bioscience Holdings Limited (NASDAQ: RGC) (“Regencell” or the “Company”), today announced that Regencell Bioscience Limited (“Regencell HK”), the Company’s wholly-owned subsidiary in Hong Kong, has entered into a joint venture agreement with Honor Epic Enterprises Limited (“Honor Epic”). The joint venture (“JV”) is expected to offer COVID-19 (“COVID”) related treatments to patients in ASEAN countries, India, Japan, Australia and New Zealand.
20 Jul, 2021
13 Apr, 2021

Related Articles